The Canadian COVID-19 Prospective Cohort Study


The Canadian COVID-19 Prospective Cohort Study (CANCOV) is a platform observational study that provides a comprehensive evaluation of early to 2-year outcomes in patients with COVID-19 and their family caregivers.

​ We are a consortium of interdisciplinary investigators and clinicians leading multiple COVID19 studies across Canada. Our research ranges from genomics and multi-omics, antibody testing and immune analyses, to physical and mental health outcomes.

​ Our overall objectives are to better understand both short and long-term outcomes in patients and their caregivers, and the predictors of those outcomes. We aim to fully characterize their genetic and clinical risk factors, functional and neuropsychological status, return to work and pattern and cost of healthcare utilization.

​ We have completed recruitment and have over 2000 (non-hospitalized and hospitalized) patients and caregivers from the four hardest-hit provinces in Canada: Quebec, Ontario, Alberta and British Columbia.

Latest News
Long COVID symptoms resolve in a year for most mild infections, study finds

Read More

What’s wrong with how we treat long COVID?

Read More

Long COVID Risk Makes It Worth Avoiding Second Infections

Read More

Our Research

Patients who are critically ill and require admission to an intensive care unit (ICU) or mechanical ventilation.


Patients who are sick enough to require admission to acute care hospitals.


Patients who are diagnosed at COVID-19 assessment centres, emergency rooms and clinics, and told to isolate at home.

Dr. Angela Cheung

Dr. Angela M. Cheung is a Professor of Medicine and the KY and Betty Ho Chair of Integrative Medicine at the University of Toronto. She is an Internal Medicine specialist and senior scientist at the University Health Network and holds a Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health. She obtained her MD from Johns Hopkins University and completed her training in General Internal Medicine at the University of Toronto and Beth Israel Deaconess Hospital in Boston, and her Ph.D. from Harvard University.

Dr. Margaret Herridge

Dr. Margaret S. Herridge is a Professor of Medicine, Critical Care and Pulmonary Medicine at the University Health Network; Senior Scientist in the Toronto General Research Institute; Director of Research for the Interdepartmental Division of Critical Care Medicine, University of Toronto. She obtained her MD from Queen’s University at Kingston, completed her clinical training in Respiratory and Critical Care Medicine at the University of Toronto and obtained her MPH at the Harvard School of Public Health.

Follow us